Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
SCYNEXIS Secures Up to $214 Million in BARDA Contract for Antifungal Development
Amount Raised
$214 Million
Round Type
Funding Round
Jersey CityBiotechnologyHealth CareInvestors
Description
On September 25, 2026, SCYNEXIS, Inc. entered into a BARDA Contract with the Biomedical Advanced Research and Development Authority. This contract provides potential non-dilutive funding of up to $214 million to support the development of SCY-247. Initially, approximately $18.5 million will be used to advance the drug into a Phase 2 study for invasive candidiasis
Fundz sees it the moment SCYNEXIS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SCYNEXIS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.